Progressive Resistance Training for Adults With External Snapping Hip
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-40
SponsorAarhus University Hospital
About this trial
External snapping hip is characterised by an audible and painful snap during hip movement among physical active people around 15-40 years old. Progressive resistance training has been suggested as a new potential treatment path in treating patients with external snapping hip. The investigators conducted a feasibility study and found that patients reported less pain and improved their physical function, quality of life and muscle strength after 12 weeks of progressive resistance training. The overall aim of the project is to compare hip pain in patients with external snapping hip treated with progressive resistance training to a wait-and-see approach, in a randomised controlled trial. This study has the potential to establish a new and specific treatment option for patients with external snapping hip, to be used nationally and internationally.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 18-40 years (10)
Experienced lateral hip joint "snapping" with pain discomfort within the last 14 days
Able to demonstrate the audible and/or visible lateral "snapping" during lateral hip joint movementor popping sound when the hip joint moves
Capable of commuting to the training facility
Disqualifiers
Previous surgery on the affected hip
Planned surgery on lower extremities within the trial period
Anterior or medial hip discomfort that substantially exceeds the lateral hip discomfort
Any contraindication to exercise
Trial design
Design model
Crossover
Treatments tested in this trial
Progressive resistance training
Other interventionThe progressive resistance program consist of a five-minute aerobic warm-up on either an ergometer bike, treadmill or rowing machine followed by six resistance training exercises: landmine twist, walking lunges, leg press, hip abduction, hip adduction and hip flexion. All training sessions (three per week) will be supervised for the first two weeks. After that, there will be one weekly supervised training session and two self-directed sessions. The subjects will be scheduled for 36 training sessions over 12 weeks, of which 16 will be supervised. Each training session is designed based on the findings from the feasibility study and is expected to last approximately one hour. If a subject cannot perform all scheduled sessions in a week, additional sessions will be planned for the following week to obtain the 16 supervised sessions.
Waiting time
Behavioral12 weeks of waiting time
Self guided exercise
Behavioral12 weeks of self guided exercise
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: Control group: Wait and see approachOther 2 interventions
Group B: Intervention group: progressive resistance trainingExperimental treatment 2 interventions
Trial outcomes
Primary outcomes
1
HAGOS Pain
The HAGOS is a patient-reported questionnaire consisting of six different subscales. The pain subscale consists of 10 questions, which are all answered using standardised answer options following a 0-4-point Likert Scale. The scores are transformed into a subscale score ranging from 0 (worst) to 100 (best). A minimal clinically relevant difference of the HAGOS pain subscale has been reported to be 9.7 points among a group of patients undergoing hip arthroscopy for femoroacetabular impingement.
Time frame
Baseline, week 6, week 12 and week 24Secondary outcomes
1
HAGOS
The remaining five subscales of HAGOS: symptoms, function in daily living (ADL), function in sport and recreation (Sports/Rec), participation in physical activities (PA) and hip and/or groin-related quality of life (QOL). The scores are transformed into a subscale score ranging from 0 (worst) to 100 (best).
Time frame
Baseline, week 6, week 12 and week 242
UCLA-AS
The patient-reported questionnaire: the University of California Los Angeles Activity Scale. There is only one question with 10 answers, ranging from 1 (worst) to 10 (best).
Time frame
Baseline, week 12 and week 243
GPE
The patient-reported questionnaire: the Global Perceived Effect, where the participant answers four questions about the effect of the treatment received. Each question has 7 possible answers, ranging from 1 (best) to 7 (worst).
Time frame
Baseline, week 12 and week 244
Single leg hop test
The objective measures include the single-leg hop for a distance test to test hip function. The hop distance is measured in cm.
Time frame
Baseline, week 12 and week 24Other outcomes
1
EQ-5D-5L
The patient-reported questionnaire: the European Quality of life 5 Dimensions with 5 Levels (EQ-5D-5L) where the participant answers six questions in relation to health-related quality of life
Time frame
Baseline, week 12 and week 242
iPCQ
The patient-reported questionnaire: the Productivity Costs Questionnaire, where information on productivity is collected .
Time frame
Baseline, week 12 and week 243
HUQ
Health Utilisation Questionnaire (HUQ) where information on healthcare and medicine is collected.
Time frame
Baseline, week 12 and week 244
Usage of analgesics due to hip-related pain
The participants will be asked if they take any analgesics due to hip-related pain. If yes, they will be further asked what type of medicine (Paracetamol/NSAID/Morfin/Other) and how often (Never/Monthly/Weekly/Daily).
Time frame
Baseline, week 12 and week 24Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Aarhus University Hospital
Lead sponsor
University of Aarhus
Collaborator
Source ClinicalTrials.gov